Nerve growth factor promotes reparative angiogenesis and inhibits endothelial apoptosis in cutaneous wounds of Type 1 diabetic mice

被引:134
|
作者
Graiani, G
Emanueli, C
Desortes, E
Van Linthout, S
Pinna, A
Figueroa, CD
Manni, L
Madeddu, P
机构
[1] Natl Inst Biostruct & Biosyst, Expt Med & Gene Thearpy Sect, I-07033 Sassari, Italy
[2] Univ Parma, Dept Pathol, I-43100 Parma, Italy
[3] Univ Austral Chile, Dept Pathol, Valdivia, Chile
[4] Sahlgrens Univ Hosp, Wallenberg Lab, Inst Cardiovasc Res, Gothenburg, Sweden
[5] Univ Sassari, I-07100 Sassari, Italy
关键词
angiogenesis; apoptosis; diabetes; vascular growth factor; wound healing;
D O I
10.1007/s00125-004-1414-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims/hypothesis. The neurotrophin nerve growth factor (NGF) is pro-angiogenic and facilitates wound repair. The present study was conducted to (i) assess the statement of NGF system components in diabetic wounds and (ii) evaluate whether NGF supplementation could prevent impairment of wound neoangiogenesis by diabetes. Methods. Skin wounds were produced in the interscapular region of streptozotocin-induced diabetic mice. NGF (1 mug per day in PBS) or vehicle was applied onto the ulcers for 3 days after punching. Non-diabetic mice were used as controls. Results. In wounds of untreated diabetic mice, endogenous levels of immunoreactive NGF were lower than those in wounds of non-diabetic mice (p<0.01). Immunohistochemical analysis showed down-regulation of tyrosine kinase receptor-A (TrkA) and up-regulation of p75 receptor in granulation tissue microvasculature. Local NFG administration prevented diabetes-induced expressional alterations, enhanced reparative capillarisation (p<0.01), and accelerated wound closure (p<0.01). This was associated with a three-fold increase in endothelial cell proliferation (p<0.01), while apoptosis was reduced by 50% (p<0.05). Quantitative RT-PCR documented a 5.5-fold increase in the expression of vascular endothelial growth factor-A (VEGF-A) by exogenous NGF in diabetic tissues (p<0.01). In in vitro preparations of human endothelial cells from derma, NGF increased the release of immunoreactive VEGF-A, and reduced high-glucose-induced apoptosis (p<0.05), the latter effect being inhibited by a VEGF-A receptor-2 antagonist. Conclusions/interpretation. Diabetic ulcers display distinct alterations in reparative angiogenesis and in the expression of NGF and its receptors. NGF supplementation corrects endogenous liabilities, facilitates vascular regeneration, and suppresses endothelial apoptosis seemingly via VEGF-A. Our findings unravel new mechanisms responsible for NGF reparative action.
引用
收藏
页码:1047 / 1054
页数:8
相关论文
共 50 条
  • [41] The possible mechanism for impaired angiogenesis after transient focal ischemia in type 2 diabetic GK rats: Different expressions of angiostatin and vascular endothelial growth factor
    Zhu, Meijia
    Bi, Xizhuang
    Jia, Qian
    Shangguan, Shina
    BIOMEDICINE & PHARMACOTHERAPY, 2010, 64 (03) : 208 - 213
  • [42] Down-regulation of hypoxia-inducible factor-1 alpha and vascular endothelial growth factor by HEXIM1 attenuates myocardial angiogenesis in hypoxic mice
    Yoshikawa, Noritada
    Shimizu, Noriaki
    Ojima, Hidenori
    Kobayashi, Hiroshi
    Hosono, Osamu
    Tanaka, Hirotoshi
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2014, 453 (03) : 600 - 605
  • [43] Transplantation of layer-by-layer assembled neural stem cells tethered with vascular endothelial growth factor reservoir promotes neurogenesis and angiogenesis after ischemic stroke in mice
    Ge, Hongfei
    Hu, Quan
    Chen, Tunan
    Yang, Yang
    Zhang, Chao
    Zhong, Jun
    Yin, Yi
    Jiang, Xuheng
    Zhou, Xin
    Wang, Shuhong
    Hu, Rong
    Li, Wenyan
    Feng, Hua
    APPLIED MATERIALS TODAY, 2022, 28
  • [44] Upregulation of soluble vascular endothelial growth factor receptor 1 contributes to angiogenesis defects in the placenta of α2B-adrenoceptor-deficient mice
    Muthig, Verena
    Gilsbach, Ralf
    Haubold, Miriam
    Philipp, Melanie
    Ivacevic, Tomi
    Gessler, Manfred
    Hein, Lutz
    CIRCULATION RESEARCH, 2007, 101 (07) : 682 - 691
  • [45] Selective Imaging of Vascular Endothelial Growth Factor Receptor-1 and Receptor-2 in Atherosclerotic Lesions in Diabetic and Non-diabetic ApoE−/− Mice
    Yared Tekabe
    Lynne L. Johnson
    Krissy Rodriquez
    Qing Li
    Marina Backer
    Joseph M. Backer
    Molecular Imaging and Biology, 2018, 20 : 85 - 93
  • [46] miR-31 ameliorates type 2 diabetic vascular damage through up-regulation of hypoxia-inducible factor-1α/vascular endothelial growth factor-A
    Fu, Yuan
    Du, Ruochen
    Wang, Yufei
    Yuan, Yitong
    Zhang, Yujuan
    Wang, Chunfang
    Zhang, Xuanping
    JOURNAL OF DIABETES INVESTIGATION, 2023, 14 (09) : 1070 - 1080
  • [47] Gene delivery of soluble vascular endothelial growth factor receptor-1 (sFlt-1) inhibits intra-plaque angiogenesis and suppresses development of atherosclerotic plaque
    Yaosheng Wang
    Yihua Zhou
    Lipeng He
    Kui Hong
    Hai Su
    Yanqing Wu
    Qinghua Wu
    Mihan Han
    Xiaoshu Cheng
    Clinical and Experimental Medicine, 2011, 11 : 113 - 121
  • [48] Nerve growth factor supplementation reverses the impairment, induced by Type 1 diabetes, of hindlimb post-ischaemic recovery in mice
    Salis, MB
    Graiani, G
    Desortes, E
    Caldwell, RB
    Madeddu, P
    Emanueli, C
    DIABETOLOGIA, 2004, 47 (06) : 1055 - 1063
  • [49] Nerve growth factor promotes ASIC1a expression via the NF-κB pathway and enhances acid-induced chondrocyte apoptosis
    Wei, Xin
    Sun, Cheng
    Zhou, Ren-Peng
    Ma, Gang-Gang
    Yang, Yang
    Lu, Chao
    Hu, Wei
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2020, 82
  • [50] Nerve growth factor supplementation reverses the impairment, induced by Type 1 diabetes, of hindlimb post-ischaemic recovery in mice
    M. B. Salis
    G. Graiani
    E. Desortes
    R. B. Caldwell
    P. Madeddu
    C. Emanueli
    Diabetologia, 2004, 47 : 1055 - 1063